Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading –for better or worse.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Ticker | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| CHM | Chimeric Therapeutic | 0.04 | 43% | 1,615,464 | $14,957,683 |
| AHN | Athena Resources | 0.004 | 33% | 137,500 | $3,211,403 |
| TON | Triton Min Ltd | 0.025 | 25% | 1,099,822 | $31,227,112 |
| CTO | Citigold Corp Ltd | 0.005 | 25% | 400,000 | $11,494,636 |
| CDT | Castle Minerals | 0.011 | 22% | 7,374,477 | $10,120,437 |
| KNM | Kneomedia Limited | 0.003 | 20% | 35,755 | $3,761,963 |
| MVL | Marvel Gold Limited | 0.012 | 20% | 43,750 | $8,637,907 |
| WC8 | Wildcat Resources | 0.55 | 20% | 6,392,662 | $478,790,772 |
| CR1 | Constellation Res | 0.13 | 18% | 93 | $5,489,597 |
| RNU | Renascor Res Ltd | 0.13 | 18% | 4,664,729 | $279,334,825 |
Chimeric Therapeutics (ASX:CHM) – Up following positive new data from a clinical trial, showing a 55% Disease Control Rate (DCR) was achieved in patients treated with CLTX CAR T, exceeding historical disease control rates of 20-37%.
Castle Minerals (ASX:CDT) – Up after the company upgraded its Kambale graphite project Mineral Resource Estimate by 38% to 22.4Mt at 8.6% TGC containing 1.9Mt.
Wildcat Resources (ASX:WC8) – Surging this morning on news of hitting 85m @ 1.25% lithium at Tabba Tabba, Including 9m at 3.0% Li2O from 199m and 13m at 2.3% Li2O from 136m.
Calidus Resources (ASX:CAI) – Up after SQM announced it’s buying 40% of Pirra Lithium from Haoma Mining NL. Calidus owns 30% of Pirra, which just found lithium 8km down the road from Wildcat at Tabba Tabba.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Ticker | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| MAP | Microbalifesciences | 0.22 | -27% | 914,723 | $90,525,320 |
| EMU | EMU NL | 0.0015 | -25% | 2,001,227 | $2,900,043 |
| GTG | Genetic Technologies | 0.002 | -20% | 1,790,999 | $28,854,145 |
| NZS | New Zealand Coastal | 0.002 | -20% | 20,170 | $4,167,525 |
| PEC | Perpetual Res Ltd | 0.015 | -19% | 66,666 | $11,445,317 |
| AL8 | Alderan Resource Ltd | 0.009 | -18% | 3,205,334 | $6,783,641 |
| FHS | Freehill Mining Ltd. | 0.0025 | -17% | 23,076 | $8,534,403 |
| MTL | Mantle Minerals Ltd | 0.0025 | -17% | 13,268,079 | $18,442,338 |
| RGL | Riversgold | 0.01 | -17% | 6,452,644 | $11,415,137 |
| NYR | Nyrada Inc. | 0.021 | -16% | 33,999 | $3,900,218 |
Microba Life Sciences (ASX:MAP) – Down sharply on news that a proposed $20 million entitlement offer to fund the acquisition of Invivo Clinical Limited (Invivo) has been fully underwritten by Bell Potter Securities and Morgans Corporate.
Riversgold (ASX:RGL) – down on news that maiden drilling has intersected 4m at 1.27% Li2O from 97m, including 1m at 2.44% Li2O from 98m at RGL’s Earl Grey East prospect.
Medallion Metals (ASX:MM8) – Down after its Ravensthorpe gold project PFS came in at 92koz per annum AuEq production and pre-tax cash flow of $85 million per annum over a 9 year mine life.